Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Idorsia Ltd.. (8/3/17). "Press Release: Idorsia Announces Half Year Results for 2017 – Successful Start of New Biopharmaceutical Company". Allschwil.

Organisations Organisation Idorsia Ltd. (SIX: IDIA)
  Group Idorsia (Group)
  Organisation 2 Johnson & Johnson (JnJ) (Group)
Products Product aprocitentan (ACT-132577)
  Product 2 ACT-541468 (Idorsia / Actelion)
Index term Index term Actelion–JnJ: investment, 201701–201706 acquisition $30b all-cash tender offer funded w JnJ cash held outside of US
Persons Person Clozel, Jean-Paul (Actelion 200607 CEO)
  Person 2 Clozel, Martine (Actelion 201108 CSO)
     


   
Record changed: 2017-08-10

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Idorsia (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px